In this study, we comprehensively characterized the expression of NPM3 on tumor cells and immune cells in lung adenocarcinoma tissues, and evaluated the correlation between NPM3 expression and clinical prognosis, gene mutations, immune cell infiltration, or immune regulatory genes using multiple biological databases. This evidence concerns the gene NPM3 and lung adenocarcinoma.